MGMT and glioblastoma: In conclusion, the results of the current study indicate that a paradoxical non-decrease in rCBV following CRT appears prognostic for improved PFS for patients with newly diagnosed IDH wild-type GBM, particularly in patients exhibiting MGMT promoter methylation.